BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Okayama University Research: Cell Membrane as Material for Bone Formation

  In a first study, the researchers observed that chondrocytes burst near the mineralized area, which they suggest might be a space-making mechanism for mineral expansion.

  February 13, 2018

   · 

  5 min read
• Drug Development

  Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial

  The two-year duration of sustained eGFR improvement in LARIAT is twice as long as Reata has previously reported for bardoxolone.

  February 13, 2018

   · 

  8 min read
• Business

  BerGenBio ASA: Results for the Fourth Quarter and Full Year 2017

  A presentation of the results by the Company’s senior management team will take place today at 10.00 am CET in Oslo - details below.

  February 13, 2018

   · 

  7 min read
• Drug Development

  Chi-Med Completes Enrollment of 527 Patients in Pivotal Phase III FALUCA Trial with Fruquintinib in Lung Cancer

  Chi-Med has completed patient enrollment of FALUCA, its Phase III pivotal trial of fruquintinib in advanced, third-line, non-small cell lung cancer (“NSCLC”) patients in China.

  February 13, 2018

   · 

  6 min read
• Business

  ivWatch Awarded Breakthrough Technology Agreement with Premier

  ivWatch, LLC has been awarded a group purchasing agreement as a Breakthrough Technology with Premier. Effective Feb.1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the ivWatch Model 400.

  February 13, 2018

   · 

  2 min read
• Genetown

  Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic Medicine

  The meeting is being held jointly with a related session, Emerging Cellular Therapies T-cells and Beyond, from February 11 to 15, 2018.

  February 13, 2018

   · 

  6 min read
• Business

  Accelerated Cure Project Launches Collaborative Research Program With Regeneron Genetics Center to Sequence DNA of Multiple Sclerosis Patients

  The RGC will use its fully-automated sample preparation and data processing, and cutting-edge cloud-based informatics to sequence the exomes in DNA samples from the ACP Repository.

  February 13, 2018

   · 

  3 min read
• Business

  Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2017 Financial Results on February 27, 2018

  Management will host a conference call and webcast discussion of the results and provide a general corporate update.

  February 13, 2018

   · 

  2 min read
• Biotech Bay

  Catalyst Biosciences Announces Pricing of Public Offering of Common Stock - Feb. 13, 2018

  Additionally, the Company has granted the underwriters an option to purchase up to an additional 441,176 shares of its common stock, at the price to the public.

  February 13, 2018

   · 

  3 min read
• Lexington Delivers 1st Generation HeartSentry for Clinical Trials

  Device completes software, mechanical and electrical tests in preparation for human study.

  February 13, 2018

   · 

  5 min read